Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “interleukin”

134 pharma patents match "interleukin" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 134
Index total 30,257
Page 4 / 6

Quick answer

This filtered view shows 134 pharmaceutical patents matching "interleukin" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

134 results for “interleukin” · 30,257 patents in full index Clear search

  1. US 9238692

    Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  2. US 9238042

    Antisense modulation of interleukins 17 and 23 signaling

    Sarepta Therapeutics, Inc. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  3. US 9173880

    Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 3, 2015 · Expires Oct 29, 2035

    granted

  4. US 9084761

    Use of interleukin-15 to treat cardiovascular diseases

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Jul 21, 2015 · Expires Jul 16, 2035

    granted

  5. US 9045559

    Method for screening inhibitors of interleukin-32 (IL-32)

    The Regents of the University of Colorado · Granted Jun 2, 2015 · Expires May 28, 2035

    granted

  6. US 8962814

    Interleukin-1α antibodies and methods of use

    XBIOTECH INC. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  7. US 8945559

    Stabilized formulations containing anti-interleukin-4 receptor (IL-4R) antibodies

    REGENERON PHARMACEUTICALS, INC. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  8. US 8603456

    Method of treating hair loss with compositions containing interleukin-1

    United Technologies UT AG · Granted Dec 10, 2013 · Expires Dec 5, 2033

    granted

  9. US 8556882

    Inducible interleukin-12

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  10. US 8388956

    Interleukin-1 alpha antibodies and methods of use

    XBIOTECH INC. · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted

  11. US 8388969

    Interleukin-1 alpha antibodies and methods of use

    XBIOTECH INC. · Granted Mar 5, 2013 · Expires Feb 28, 2033

    granted

  12. US 8323635

    Methods of using interleukin-1 receptor antagonist as a myeloprotective agent

    GENERAL REGENERATIVES, LTD. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted

  13. US 8298523

    Compositions containing interleukin-1 and peptides

    United Technologies UT AG · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  14. US 8133915

    Interleukin-1 and tumor necrosis factor-α modulators; syntheses of such modulators and methods of using such modulators

    The Regents of the University of California · Granted Mar 13, 2012 · Expires Mar 8, 2032

    granted

  15. US 8119631

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Feb 21, 2012 · Expires Feb 16, 2032

    granted

  16. US 8067390

    Therapeutic targeting of interleukins using siRNA in neutral liposomes

    The Board of Regents of the University of Texas System · Granted Nov 29, 2011 · Expires Nov 24, 2031

    granted

  17. US 8034337

    Interleukin-1α antibodies

    XBIOTECH INC. · Granted Oct 11, 2011 · Expires Oct 6, 2031

    granted

  18. US 7981409

    Method of reducing aging of skin by applying interleukin-1 alpha

    United Technologies UT AG · Granted Jul 19, 2011 · Expires Jul 14, 2031

    granted

  19. US 7893299

    Interleukin-1 and tumor necrosis factor-αmodulators; syntheses of such modulators and methods of using such modulators

    The Regents of the University of California · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted

  20. US 7790713

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Sep 7, 2010 · Expires Sep 2, 2030

    granted

  21. US 7772366

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted

  22. US 7449201

    Storage stable power compositions of interleukin-4 receptor

    Nektar Therapeutics · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted

  23. US 7381405

    Methods of preparing lymphocytes that express interleukin-2 and their use in the treatment of cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Jun 3, 2008 · Expires May 29, 2028

    granted

  24. US 7288671

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.